# Surgery of Melanoma Metastases After Systemic Therapy

> **NCT04242329** · PHASE2 · WITHDRAWN · sponsor: **Vastra Gotaland Region**

## Conditions studied

- Melanoma
- Melanoma Stage IV
- Metastatic Melanoma
- Surgery

## Interventions

- **PROCEDURE:** Surgical metastasectomy
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT04242329
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03-11
- **Primary completion:** 2023-09-03
- **Final completion:** 2023-09-13
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not possible to recruit patients during COVID, and not possible to start enrolling after the pandemic.
- **Last updated:** 2024-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04242329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04242329, "Surgery of Melanoma Metastases After Systemic Therapy". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04242329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*